<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sabrina Chris Janiba Sanvee</style></author><author><style face="normal" font="default" size="100%">Bignoate Kombate</style></author><author><style face="normal" font="default" size="100%">Yendubé Toughelighan Kantati</style></author><author><style face="normal" font="default" size="100%">Pascaline Kindji Kpoyizoun</style></author><author><style face="normal" font="default" size="100%">Essotolom Badjabaissi</style></author><author><style face="normal" font="default" size="100%">Mindede Assih1 Aboudoulatif Diallo</style></author><author><style face="normal" font="default" size="100%">Batomayena Bakoma</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Phytochemistry, Antihyperglycemic, Antioxidant and Anti- Inflammatory Properties of Uvaria Chamae and Sida Linifolia Extracts: Potential Implication in Diabetic Disease</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Decoction</style></keyword><keyword><style  face="normal" font="default" size="100%">hyperglycemia</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroprotection</style></keyword><keyword><style  face="normal" font="default" size="100%">Phytochemistry</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">582-590</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; Uvaria chamae and Sida linifolia are plants traditionally used in Togo in diabetes treatment, an affection that often leads to several complications. This study aimed to evaluate the antihyperglycemic, anti-inflammatory, antioxidant activity and toxicity of these two plants extracts.&lt;strong&gt; Methods:&lt;/strong&gt; A phytochemical analysis was carried out on extracts obtained either by decoction or maceration in ethanol of Uvaria chamae leaves and Sida linifolia whole plant. Evaluation of the antihyperglycemic activity consisted in glucose absorption test using yeast and rats’ muscle and jejunum. DPPH test, total antioxidant capacity assay, hemolysis and egg albumin denaturation inhibition assays and evaluation of extracts acute toxicity were performed. &lt;strong&gt;Results: &lt;/strong&gt;Hydroalcoholic extract of Uvaria chamae showed the strongest antihyperglycemic activity (p&amp;lt;0.05); the highest phenolic contents (147.93 ± 1.01 mg/g), the best total antioxidant capacity (153.33 ± 4.07), the lowest IC50 (μg/mL) for DPPH test (296.96 ± 91.69), a capacity of hemolysis (825.99 ± 29.24) and egg albumin denaturation (738.10 ± 92.26) inhibition assays. In the same way, hydroalcoholic extract of Sida linifolia, showed the strongest antihyperglycemic activity (p&amp;lt;0.05), the highest phenolic contents (71.60 ± 2.16 mg/g), the best total antioxidant capacity (146.98 ± 2.81), lowest IC50 (μg/ mL) for DPPH test (788.28 ± 112.54), the hemolysis (882.03 ± 20.86) and egg albumin denaturation (1966.18 ± 35.94) inhibition assays. None of the extracts showed acute toxicity in rats. &lt;strong&gt;Conclusion: &lt;/strong&gt;the hydroalcoholic leaves extract of Uvaria chamae and of the whole plant of Sida linifolia could be candidates in the treatment of diabetes and its complications.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">582-590</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Sabrina Chris Janiba Sanvee&lt;sup&gt;1&lt;/sup&gt;*, Bignoate Kombate², Yendubé Toughelighan Kantati², Pascaline Kindji Kpoyizoun², Essotolom Badjabaissi&lt;sup&gt;1&lt;/sup&gt;, Mindede Assih&lt;sup&gt;1&lt;/sup&gt; Aboudoulatif Diallo&lt;sup&gt;1&lt;/sup&gt; Batomayena Bakoma&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Laboratory of Pharmaceutical Science, Faculty of Health Sciences, University of Lomé, Lomé- Togo, 01BP 1515, LOME.&lt;/p&gt;

&lt;p&gt;²Laboratory of Physiology/Pharmacology, Physiopathology Bioactive Substances and Innocuity Research Unit (PBSI), Faculty of Sciences, University of Lomé, Lomé - Togo, 01BP 1515. LOME.&lt;/p&gt;
</style></auth-address></record></records></xml>